Colin Farrell’s New Foundation: A Powerful Reminder of Advocacy’s Roots
Over the past couple of weeks, the media was filled with articles and clips of actor Colin Farrell. He wasn’t promoting a new movie this time, but bringing his considerable…
Blog
: General
It’s Complicated: The Industry/Patient Advocacy Organization Relationship
Last week, Adam Feuerstein of STAT+ posted a news story that underscored the complexity of relationships between patient organizations and pharmaceutical companies. See story here. According to STAT, the…
- by: Heidi Adams
August 5, 2024
Joint Statement from Pyxis Partners and Rx4good on New Details Regarding FDA Requirements on Diversity Action Plans for Certain Clinical Studies
As partners dedicated to advancing diversity and inclusivity in clinical trials, Pyxis Partners and Rx4good welcome the recently released U.S. Food and Drug Administration (FDA) draft guidance on diversity action plan requirements for…
Pyxis Partners and Rx4good Unite to Guide Biopharmaceutical Companies in Diversifying Clinical Trials
Diversity action plan requirements, when finalized by FDA, will improve inclusion of communities historically underrepresented in medical research. Washington, DC (March 5, 2024) – Recently members of the Congressional Committee…
The Era of Diversity Action Plans is Here: Are You Ready?
Increasing clinical trial diversity has become a top priority for many pharmaceutical companies in recent years. With the FDA soon to finalize guidance on mandated Diversity Action Plans for phase…
